Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer

Prostate-specific membrane antigen (PSMA) targeting radiopharmaceuticals have been successfully used for diagnosis and therapy of prostate cancer. Optimization of the available agents is desirable to improve tumor uptake and reduce side effects to non-target organs. This can be achieved, for instanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Murce, Erika, Beekman, Savanne, Spaan, Evelien, Handula, Maryana, Stuurman, Debra, de Ridder, Corrina, Seimbille, Yann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223019/
https://www.ncbi.nlm.nih.gov/pubmed/37241763
http://dx.doi.org/10.3390/molecules28104022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223019/
https://www.ncbi.nlm.nih.gov/pubmed/37241763
http://dx.doi.org/10.3390/molecules28104022

Ejemplares similares